Loading profile...
Andrew Lane
Andrew Lane has more than 30 years of experience in the global pharmaceutical industry. He was appointed Independent Non-Executive Director of AFT Pharmaceuticals on 28 September 2023. Most recently, Andrew served as Global President of the Pharma Division at Abbott Laboratories, where he led a multi-billion-dollar operation with 30 manufacturing plants, 12 Innovation and Development sites, and 40,000 staff covering more than 100 countries. During his tenure, turnover grew from NZ$4 billion to over NZ$9 billion. Previously, he was Vice President, Asia Pacific at Takeda Pharmaceuticals, managing operations in 12 countries including three factories and 2,000 staff. Prior to Abbott and Takeda, he had a 20-year career in developing countries with Nycomed, Invida/DKSH, Novartis, and Sandoz. Andrew's expertise spans finance, manufacturing, sales, marketing, strategy, and general management at regional and global levels. He holds an Accounting/Business Management degree from Auckland University of Technology (1988-1991).
Current Positions
- Committee Member/Toy Buyer at Woodend Toy Library Incorporated (charity)
- Director at Tania Dalton Foundation (charity)
- at Ryman Healthcare Limited (issuer)
- Trustee at Tania Dalton Foundation (charity)
- CEO — Chief Executive Officer at Precinct Properties New Zealand Limited (executive)
Education
Accounting/Business Management, Auckland University of Technology (1988-1991)
About this profile
This profile aggregates publicly-available information from 6 source registers for the purpose of cross-platform governance and transparency research. Every fact is sourced from one of the public publications listed below; the aggregation, presentation and any analytical observations are published by NZXplorer.
Source registers used on this page
- NZX market announcements and continuous-disclosure filings
- Audited annual reports lodged with NZX
- FMA Disclose Register (substantial product holders, insider trades)
- NZ Companies Office records (Companies Act 1993 §215)
- NZ Government Gazette appointment notices
- Issuer earnings webcasts and investor presentations
If anything on this page is wrong, missing context, or warrants a formal right-of-reply, use the dispute & right-of-reply form. Our editorial floor — what we always remove on request, the search-engine indexing policy, and the Privacy Act access / correction routes — is set out on Data Principles.